403 related articles for article (PubMed ID: 33302035)
1. Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective.
Bolarin JA; Oluwatoyosi MA; Orege JI; Ayeni EA; Ibrahim YA; Adeyemi SB; Tiamiyu BB; Gbadegesin LA; Akinyemi TO; Odoh CK; Umeobi HI; Adeoye AB
Int Immunopharmacol; 2021 Jan; 90():107228. PubMed ID: 33302035
[TBL] [Abstract][Full Text] [Related]
2. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
Lisi L; Lacal PM; Barbaccia ML; Graziani G
Biochem Pharmacol; 2020 Oct; 180():114169. PubMed ID: 32710969
[TBL] [Abstract][Full Text] [Related]
3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
4. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
5. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
6. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
7. Molnupiravir and Its Antiviral Activity Against COVID-19.
Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J
Front Immunol; 2022; 13():855496. PubMed ID: 35444647
[TBL] [Abstract][Full Text] [Related]
8. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
Debnath SK; Debnath M; Srivastava R; Omri A
Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
[TBL] [Abstract][Full Text] [Related]
9. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
Uzunova K; Filipova E; Pavlova V; Vekov T
Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
Mishra J; Prasun C; Sahoo PK; Nair MS
Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
[TBL] [Abstract][Full Text] [Related]
11. Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices.
Saha T; Quiñones-Mateu ME; Das SC
Int J Pharm; 2022 Aug; 624():122042. PubMed ID: 35868481
[TBL] [Abstract][Full Text] [Related]
12. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
13. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
Krishna G; Pillai VS; Veettil MV
Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
[TBL] [Abstract][Full Text] [Related]
14. Current therapies under investigation for COVID-19: potential COVID-19 treatments.
Weisberg E; Sattler M; Yang PL; Parent A; Gray N; Griffin JD
Can J Physiol Pharmacol; 2020 Aug; 98(8):483-489. PubMed ID: 32640179
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy for coronavirus disease 2019.
Gong S; Su J; Yan X; Li F; Hu L; Liu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):598-602. PubMed ID: 32879113
[TBL] [Abstract][Full Text] [Related]
16. Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19.
Ünlü B; Simsek R; Köse SBE; Yirün A; Erkekoglu P
Mini Rev Med Chem; 2022; 22(2):213-231. PubMed ID: 34191697
[TBL] [Abstract][Full Text] [Related]
17. An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms.
Dinda B; Dinda M; Dinda S; De UC
Eur J Med Chem; 2023 Oct; 258():115629. PubMed ID: 37437351
[TBL] [Abstract][Full Text] [Related]
18. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
Abd El-Aziz TM; Stockand JD
Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of repurposed antiviral drugs: Lessons from COVID-19.
Martinez MA
Drug Discov Today; 2022 Jul; 27(7):1954-1960. PubMed ID: 35192924
[TBL] [Abstract][Full Text] [Related]
20. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.
Khazir J; Maqbool T; Mir BA
Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]